Infectious Disease Excellence Program (IDEP)
Certification in Infectious Disease Management
1 / 10
1. What was the Azithromycin dosing regimen used in the 2003 IJDVL acne study?
2 / 10
2. What topical therapy was administered alongside both oral regimens in the 2003 acne study?
3 / 10
3. How was the study titled “Comparison of Oral Azithromycin Pulse with Daily Doxycycline in Acne Vulgaris” designed?
4 / 10
4. According to the 2003 IJDVL study, what was the mean percentage improvement in acne severity with Azithromycin pulse therapy?
5 / 10
5. According to the study, why is Azithromycin an appealing option for adolescent acne patients?
6 / 10
6. Which adverse event was reported with Doxycycline but not with Azithromycin in the IJDVL study?
7 / 10
7. What was the main clinical advantage of pulse Azithromycin therapy shown in the IJDVL acne study?
8 / 10
8. What pharmacokinetic property of Azithromycin supports its pulse dosing strategy?
9 / 10
9. What was the mean post-treatment acne severity index for patients on Doxycycline, as reported in the study?
10 / 10
10. In the same study, what percentage of patients on Azithromycin achieved >80% lesion clearance?
Your score is
©2025 acpnepalcme
